[PDF] MP85-13 ERECTILE FUNCTION IN 478 HYPOGONADAL MENWITH MODERATE TO SEVERE ED WITH AND WITHOUT TESTOSTERONETHERAPY FOR UP TO …
A Haider, KS Haider, G Doros, A Traish – The Journal of Urology, 2018
METHODS 478 menwith testosterone≤ 350 ng/dL and hypogonadal symptoms had
moderate to severe ED according to IIEF-EF (5+ 1, maximum score: 30). 246
received testosteroneundecanoate injections (TU) 1000 mg/12 weeks following an …
[PDF] MP85-15 TESTOSTERONETREATMENT IN MENWITH CLASSICAL VS FUNCTIONAL HYPOGONADISM: RESULTS FROM A 9-YEAR-REGISTRY
M Zitzmann, E Nieschlag, A Traish, S Kliesch – The Journal of Urology, 2018
METHODS Registry data of max. 9 years comprising 650 patients with
hypogonadism including 266 menwith primary (mean age 34.0±11.7 years), 196
with secondary (mean age 31.9±12.0 years) and 188 with functional hypogonadism …
[PDF] PD62-05 BRIDGING THE GAP BETWEEN LOW TESTOSTERONEAND PROSTATE INFLAMMATION IN HYPOGONADAL MEN
A Gabrielson, A Reddy, A Sholl, L Alzweri… – The Journal of Urology, 2018
METHODS Twenty prostate specimens from patients (10 hypogonadal, 10
eugonadal) were stained for p65 (NF-? B) and TGF-β receptor (TGF-βR) expression.
Patients were stratified by pre-RP testosterone:< 300 ng/dL as hypogonadal,> 400 …
[PDF] MP85-14 VARIANCE IN PEAK AND TROUGH TESTOSTERONELEVELS IN MENUSING INTRAMUSCULAR TESTOSTERONE
B Nascimento, HL Bernie, E Schofield, JP Mulhall – The Journal of Urology, 2018
METHODS Patients with 3 consecutive Tp and Tt levels available, while on a stable
dose and interval of IM T cypionate were analyzed. All patients were instructed as
follows: Tp levels to checked 18 hours after IM T injection, and Tt levels to be drawn …
MP85-06 TOREMIFENE CITRATE IMPROVES HIGH-DENSITY LIPOPROTEIN LEVELS IN MENON TESTOSTERONEREPLACEMENT THERAPY
DJ Mazur, TP Kohn, A Perez-Orozco, JA McBride… – The Journal of Urology, 2018
METHODS Menon TTh with low HDL levels (< 39 mg/dL) at a single andrology clinic
treated between October 2015 and August 2017 with either toremifine (60 mg daily),
niacin (titrated to 1,000 mg daily over 2 months) plus krill oil (1,000 mg daily)(NKO) …
MP80-20 USE OF NON-TESTOSTERONEBASED HORMONE THERAPIES AMONG PRIVATELY INSURED US MEN, 2009-2015
M Henry, D Patil, A Nangia, A Mehta – The Journal of Urology, 2018
METHODS We used 2009-2015 Truven Health MarketScan Data to identify men
using T & non-T hormone therapies (clomiphene citrate, aromatase inhibitors, human
chorionic gonadotropin (hCG), & follicle stimulating hormone (FSH)), using National.
